Table of Contents
ISRN Vascular Medicine
Volume 2013 (2013), Article ID 985743, 10 pages
Research Article

Association of Leukotriene Gene Variants and Plasma LTB4 Levels with Coronary Artery Disease in Asian Indians

1Mary and Garry Weston Functional Genomics Unit, Thrombosis Research Institute, Narayana Hrudayalaya 258/A, Bommasandra Industrial Area, Anekal Taluk, Bangalore, Karnataka 560099, India
2Thrombosis Research Institute, Bangalore 560099, India
3Thrombosis Research Institute, London, SW3 6LR, UK

Received 24 April 2013; Accepted 14 May 2013

Academic Editors: D. Guidolin, A. Mugge, B. Tesfamariam, and C.-C. Wu

Copyright © 2013 Jiny Nair et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Leukotrienes are potent inflammatory and lipid mediators that participate in atherosclerosis. We analyzed the association of Leukotriene gene (ALOX5, ALOX5AP, LTA4H, and LTC4S) polymorphisms and plasma Leukotriene B4 (LTB4) levels with coronary artery disease (CAD) in a representative cohort of Asian Indians. In all, 136 functional single nucleotide polymorphisms (SNPs) were selected using in silico tools. Forty-five polymorphic SNPs were ranked for predicted functional effect using FastSNP. Finally, 14 functional SNPs along with 10 SNPs identified from the literature were genotyped in 340 CAD patients and 340 controls. Plasma LTB4 levels were measured in 150 cases and 150 controls. None of the 24 SNPs showed significant association with CAD. Plasma LTB4 levels were higher in cases than in controls (  pg/mL versus  pg/mL) ( ), with greater risk being associated with the top quartile as compared to the bottom quartile after adjusting for potential confounders (OR 8.94, 95% CI 2.56–31.95; ). Four SNPs in the LTA4H gene showed significant association with LTB4 levels ( ) of which rs1978331 ( ) remained significant after correction for multiple testing. LTB4 showed strong correlation with lipids ( –34) only in cases. Our pilot study suggests that the association between Leukotrienes gene polymorphisms and CAD risk may be modulated through plasma LTB4 levels.